new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Hanmi Pharm Co Ltd
Hanmi Pharm Co Ltd_20100107
  

Hanmi Pharm Co Ltd patents

Recent patent applications related to Hanmi Pharm Co Ltd. Hanmi Pharm Co Ltd is listed as an Agent/Assignee. Note: Hanmi Pharm Co Ltd may have other listings under different names/spellings. We're not affiliated with Hanmi Pharm Co Ltd, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "H" | Hanmi Pharm Co Ltd-related inventors




Date Hanmi Pharm Co Ltd patents (updated weekly) - BOOKMARK this page
03/09/17Bicyclic derivatives and pharmaceutical composition including the same
03/09/17Novel insulin analogs and use thereof
02/02/17Pharmaceutical combination formulation comprising amlodipine, losartan and rosuvastatin
12/22/16Complex granule formulation having improved stability comprising levocetirizine and montelukast
12/01/16Composite formulation for oral administration comprising ezetimibe and rosuvastatin
09/15/16Composite formulation comprising tadalafil and amlodipine
07/28/16Formulation of long-acting human growth hormone conjugate
07/28/16Method for mass production of factor vii/viia derivatives
07/14/16Composition for treating hyperlipidemia comprising oxyntomodulin derivative
06/09/16Conjugate of biologically active polypeptide monomer and immunoglobulin fc fragment with reduced receptor-mediated clearance, and the preparing the same
06/02/16Immunoglobulin fc conjugate which maintains binding affinity of immunoglobulin fc fragment to fcrn
05/12/16Igg4 fc fragment comprising modified hinge region
03/31/16Capsule formulation comprising montelukast and levocetirizine
02/18/16Composite formulation comprising a film coating layer containing rosuvastatin or a pharmaceutically acceptable salt thereof
01/14/16Novel insulin analog and use thereof
01/14/16Improved preparation high-yield production of physiologically active polypeptide conjugate
01/07/16Site-specific insulin conjugate
12/17/15A virus inactivation in composition comprising factor vii
12/17/15Recombinant yeast transformant and process for preparing immunoglobulin fc fragment employing the same
12/03/15Method for preparing 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)prop-2-en-1-one
12/03/15Method for preparing 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)prop-2-en-1-one
11/19/15Insulinotropic peptide derivative with modified n-terminal charge
10/22/15A composition for treating diabetes or diabesity comprising oxyntomodulin analog
10/22/15Novel imidazopyridine derivatives as a tyrosine kinase inhibitor
10/22/15A composition for treating diabetes or diabesity comprising oxyntomodulin analog
10/15/15Liquid formulation of protein conjugate comprising the oxyntomodulin and an immunoglobulin fragment
10/15/15Liquid formulation of protein conjugate comprising the oxyntomodulin and an immunoglobulin fragment
10/08/15Dry powder for inhalation formulation comprising salmeterol xinafoate, fluticasone propionate and tiotropium bromide, and preparing same
10/01/15Solid dispersion with improved solubility comprising tetrazole derivative as an active ingredient
08/27/15Liquid formulation of long acting insulinotropic peptide conjugate
08/20/15Pharmaceutical composite capsule formulation comprising irbesartan and hmg-coa reductase inhibitor
07/30/15Bilayered composite tablet formulation comprising atorvastatin, irbesartan and magnesium carbonate
07/16/15Liquid formulation of long-acting insulin conjugate
07/09/15Liquid formulation of long-acting insulin and insulinotropic peptide
07/09/15Isoquinoline-5-carboxamide derivative having inhibitory activity for protein kinase
07/02/15Composition for treating hyperlipidemia comprising oxyntomodulin derivative
06/11/15Dry powder for inhalation formulation comprising salmeterol xinafoate, fluticasone propionate and tiotropium bromide, and preparing same
04/09/15Composite formulation comprising multi-unit spheroidal tablet (must) encapsulated in hard capsule and preparing same
12/18/14Thieno[3,2-d]pyrimidine derivatives having inhibitory activity for protein kinases
12/11/14Triazolopyridine derivatives as a tyrosine kinase inhibitor
12/04/14Stable pharmaceutical formulation for oral administration comprising levocetirizine or a pharmaceutically acceptable salt thereof, and montelukast or a pharmaceutically acceptable salt thereof
10/23/14Oral complex formulation comprising omega-3 fatty acid and hmg-coa reductase inhibitor with improved stability
08/14/14Composite formulation comprising a tablet encapsulated in a hard capsule
06/19/14Capsule formulation comprising montelukast and levocetirizine
04/24/14Pharmaceutical composition comprising amide derivative inhibiting the growth of cancer cells and non-metallic salt lubricant
01/09/14Oral complex composition comprising omega-3 fatty acid ester and hmg-coa reductase inhibitor
10/17/13New bicyclic compound for modulating g protein-coupled receptors
11/29/12Bicyclic heteroaryl derivatives having inhibitory activity for protein kinase
05/10/12Method for preparing rapidly disintegrating formulation for oral administration
05/05/11Method for preparation of montelukast acid in ionic liquid medium
12/16/10Method of preparing taxane derivatives and intermediates used therein
10/28/10Method of preparing (6r)-3-hexyl-4-hydroxy-6-undecyl-5, 6-dihydropyran-2-one, and intermediate used in the method
10/07/10Protein complex using an immunoglobulin fragment and the preparation thereof
09/30/10Methods for preparing capecitabine and beta-anomer-rich trialkyl carbonate compound used therein
09/16/10Pharmaceutical composition comprising amlodipine and losartan
07/29/10Process for preparing voriconazole
07/15/10Novel amide derivative for inhibiting the growth of cancer cells
07/01/10Process for preparing bepotastine and intermediates used therein
06/03/10Novel crystalline bepotastine metal salt hydrate, preparing same, and pharmaceutical composition comprising same
05/13/10Atorvastatin strontium salt and pharmaceutical composition comprising same
04/29/10Method for preparing rapidly disintegrating formulation for oral administration and preparing and packing the same
04/29/10Physiologically active polypeptide conjugate having prolonged in vivo half-life
04/22/10Method of preparing docetaxel and intermediates used therein
04/22/10Method of preparing s-(-)-amlodipine or a salt thereof and an intermediate used therein
04/22/10Method of preparing montelukast and intermediates used therein
Patent Packs
04/22/10Stable anhydrous crystalline docetaxel and the preparation thereof
02/25/10Complex formulation for preventing or treating osteoporosis which comprises solid dispersion of vitamin d or its derivative and bisphosphonate
01/07/10Controlled release complex formulation for oral administration of medicine for diabetes and the preparation thereof
12/31/09(s)-(-)-amlodipine camsylate or hydrate thereof and pharmaceutical composition comprising same
12/24/09Crystalline azithromycin l-malate monohydrate and pharmaceutical composition containing same
12/24/09Method preparation clopidogrel and intermediates used therein
10/15/09Crystalline s-omeprazole strontium hydrate, preparing same, and pharmaceutical composition containing same
08/20/09Pharmaceutical composition containing clopidogrel camphorsulfonate or polymorphic forms thereof
02/05/09Method for preparing clopidogrel 1,5-naphthalenedisulfonate or hydrate thereof
01/07/10Controlled release complex formulation for oral administration of medicine for diabetes and the preparation thereof







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Hanmi Pharm Co Ltd in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Hanmi Pharm Co Ltd with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';